11 Apr NexPlasmaGen is a TieQuest 2026 finalist for the Grand Final
Montreal / April 11, 2026 – NexPlasmaGen is immensely proud to announce that it is a finalist in the Medical Device category of the prestigious TieQuest 2026 competition and is...
Small Image With Sidebar
27 Feb NexPlasmaGen at Invest-Tech on March 19 in Montréal!
We are proud to announce that NexPlasmaGen will be participating to the 6th edition of Invest-Tech, Québec’s must-attend event for innovative startups in AI, Deep Tech, and Med/Biotech! 📍 When &...
20 Feb New member of NexPlasmaGen’s Business Advisory Committee
February 20, 2026, New member of NexPlasmaGen's Business Advisory Committee Montreal / February 20, 2026 – NexPlasmaGen is immensely proud to announce that Mr. Howard Hechler has joined NexPlasmaGen's Business Advisory...
22 Aug NexPlasmaGen New Board Member
Montreal / August 21, 2025 - NexPlasmaGen is pleased to announce that Mr. Suman Mallick has joined NexPlasmaGen board! Suman Mallick is a Managing Director at Keystone National Group, where is...
24 Jul NexPlasmaGen Secures Patent in South Korea
Montreal / July 24, 2025 – NexPlasmaGen is proud to announce that it has secured a patent in South Korea to protect its Convertible Plasma Jet (CPJ) technology for breast...
25 Apr Clinical trials protocol published in BMC Cancer journal
Montreal / April 25, 2025 – Clinical researchers at the University of Montreal Hospital Center (CHUM) have published in the journal BMC Cancer the clinical protocol for human safety trials initiated...